Sciencast Management LP acquired a new stake in shares of Cognex Corporation (NASDAQ:CGNX) during the second quarter, according to its most recent filing with the SEC. The fund acquired 9,900 shares of the scientific and technical instruments company’s stock, valued at approximately $841,000.

Several other large investors also recently added to or reduced their stakes in the stock. State Street Corp raised its stake in shares of Cognex Corporation by 2.2% during the 2nd quarter. State Street Corp now owns 2,169,073 shares of the scientific and technical instruments company’s stock valued at $184,153,000 after purchasing an additional 45,840 shares during the period. Shelton Capital Management bought a new stake in shares of Cognex Corporation during the 2nd quarter valued at $550,000. Whale Rock Capital Management LLC bought a new stake in shares of Cognex Corporation during the 2nd quarter valued at $17,063,000. Macquarie Group Ltd. raised its stake in shares of Cognex Corporation by 99.9% during the 2nd quarter. Macquarie Group Ltd. now owns 75,903 shares of the scientific and technical instruments company’s stock valued at $6,444,000 after purchasing an additional 37,938 shares during the period. Finally, Flinton Capital Management LLC raised its stake in shares of Cognex Corporation by 70.0% during the 2nd quarter. Flinton Capital Management LLC now owns 4,080 shares of the scientific and technical instruments company’s stock valued at $346,000 after purchasing an additional 1,680 shares during the period. Institutional investors own 87.25% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “9,900 Shares in Cognex Corporation (CGNX) Purchased by Sciencast Management LP” was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at https://www.watchlistnews.com/9900-shares-in-cognex-corporation-cgnx-purchased-by-sciencast-management-lp/1613144.html.

CGNX has been the topic of a number of analyst reports. Cowen and Company reiterated a “buy” rating and set a $100.00 price objective on shares of Cognex Corporation in a research note on Tuesday, July 11th. Zacks Investment Research upgraded Cognex Corporation from a “hold” rating to a “buy” rating and set a $95.00 price objective on the stock in a research note on Tuesday, July 4th. BidaskClub lowered Cognex Corporation from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 30th. Finally, Wolfe Research upgraded Cognex Corporation from a “market perform” rating to an “outperform” rating in a research note on Monday, August 14th. Six investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Cognex Corporation presently has a consensus rating of “Buy” and an average price target of $82.75.

In related news, CEO Robert Willett sold 8,241 shares of Cognex Corporation stock in a transaction dated Friday, August 25th. The stock was sold at an average price of $103.09, for a total value of $849,564.69. Following the completion of the transaction, the chief executive officer now owns 8,241 shares in the company, valued at $849,564.69. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Patrick Alias sold 5,000 shares of Cognex Corporation stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $111.31, for a total value of $556,550.00. Following the completion of the transaction, the director now owns 5,000 shares of the company’s stock, valued at approximately $556,550. The disclosure for this sale can be found here. In the last quarter, insiders sold 126,750 shares of company stock valued at $13,242,726. 5.60% of the stock is currently owned by company insiders.

Shares of Cognex Corporation (NASDAQ CGNX) traded up 1.1418% during trading on Friday, reaching $116.9402. The company’s stock had a trading volume of 254,062 shares. The company has a market cap of $10.12 billion, a PE ratio of 53.4217 and a beta of 1.42. The company has a 50 day moving average of $108.95 and a 200 day moving average of $94.75. Cognex Corporation has a 12-month low of $49.68 and a 12-month high of $116.99.

Cognex Corporation (NASDAQ:CGNX) last released its quarterly earnings results on Monday, July 31st. The scientific and technical instruments company reported $0.63 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.55 by $0.08. The company had revenue of $172.90 million during the quarter, compared to analyst estimates of $169.79 million. Cognex Corporation had a return on equity of 19.51% and a net margin of 33.10%. The firm’s revenue was up 17.4% on a year-over-year basis. During the same quarter last year, the business posted $0.50 earnings per share. On average, analysts anticipate that Cognex Corporation will post $2.55 EPS for the current fiscal year.

Cognex Corporation Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Institutional Ownership by Quarter for Cognex Corporation (NASDAQ:CGNX)

Receive News & Ratings for Cognex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.